<div><div></div><div>Bluejay Diagnostics completed a private placement, entering a securities purchase agreement and a related registration rights agreement with institutional accredited investors. The offering, which closed on June 5, 2026, generated approximately $7.7 million in net proceeds and included pre-funded warrants and Series G and H warrants, with unit pricing at $2.324 and warrant exercise prices of $0.0001 (pre-funded) and $2.075 (Series G/H). H.C. Wainwright acted as placement agent and received cash fees and placement agent warrants. The company agreed to file and maintain a resale registration to facilitate investor liquidity.Agreement 1: Bluejay Diagnostics Closes $7.7 Million Private Placement of Pre-Funded and Common Warrants<ul><li>Agreement type: Securities purchase agreement for private placement of pre-funded and common warrants</li><li>Counterparty: Institutional Accredited Investors</li><li>Signed / Effective: Jun 02 2026 / Jun 05 2026</li><li>Duration / Termination: At will</li><li>Reason: Raise capital with warrant coverage</li></ul>Agreement 2: Bluejay Diagnostics Enters Resale Registration Rights Agreement for Warrant Shares<ul><li>Agreement type: Registration rights agreement for resale of warrant shares</li><li>Counterparty: Institutional Accredited Investors</li><li>Signed / Effective: Jun 02 2026 / Jun 02 2026</li><li>Duration / Termination: Until all shares can be sold or under Rule 144</li><li>Reason: Provide liquidity for investors via registered resale</li></ul>Original SEC Filing: Bluejay Diagnostics, Inc. [ BJDX ] - 8-K - Jun. 08, 2026<section>Disclaimer<div>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</div></section></div></div>

BJDX

Bluejay Diagnostics completed a $7.7 million private placement on June 5, 2026, selling pre-funded and Series G/H warrants at $2.324 per unit. H.C. Wainwright served as placement agent. The company also entered a resale registration rights agreement to facilitate investor liquidity for the warrant shares.

Bluejay Diagnostics Raises $7.7 Million in Private Placement, Issues Pre-Funded and 5-Year Warrants